Besides, our group also discovered some favorable FGFR1 inhibitors L16H50 (Wu et al., 2017a), L6123 (Xu et al., 2015), and Af23 (Wu et al., 2015), which exhibited effective anti-gastric cancer effects in vitro. This evidence concerns the gene FGFR1 and gastric cancer.